Camber Capital Management as of June 30, 2014
Portfolio Holdings for Camber Capital Management
Camber Capital Management holds 40 positions in its portfolio as reported in the June 2014 quarterly 13F filing
Company (Ticker) |
Portfolio Weight |
Valued At |
Change in Shares |
Share Count |
Share Price |
|---|---|---|---|---|---|
| Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY) | 19.2 | $294M | 1.5M | 195.72 | |
| Teva Pharmaceutical Industries (TEVA) | 7.7 | $118M | 2.3M | 52.42 | |
| WellPoint | 4.9 | $75M | 700k | 107.61 | |
| Quest Diagnostics Incorporated (DGX) | 4.2 | $65M | 1.1M | 58.69 | |
| Community Health Systems (CYH) | 4.1 | $63M | 1.4M | 45.37 | |
| CONMED Corporation (CNMD) | 4.0 | $61M | 1.4M | 44.15 | |
| Volcano Corporation | 3.6 | $56M | 3.2M | 17.61 | |
| Mylan | 3.4 | $52M | 1.0M | 51.56 | |
| Hca Holdings (HCA) | 3.3 | $51M | 900k | 56.38 | |
| Genomic Health | 3.1 | $47M | 1.7M | 27.40 | |
| Keryx Biopharmaceuticals | 3.0 | $46M | 3.0M | 15.38 | |
| Achillion Pharmaceuticals | 2.9 | $44M | 5.8M | 7.57 | |
| Masimo Corporation (MASI) | 2.8 | $43M | 1.8M | 23.60 | |
| Tenet Healthcare Corporation (THC) | 2.8 | $42M | 900k | 46.94 | |
| Laboratory Corp. of America Holdings | 2.7 | $41M | 400k | 102.40 | |
| Hill-Rom Holdings | 2.4 | $37M | 893k | 41.51 | |
| Haemonetics Corporation (HAE) | 2.3 | $35M | 1.0M | 35.28 | |
| Universal American | 2.3 | $35M | 4.2M | 8.33 | |
| Ariad Pharmaceuticals | 2.1 | $32M | 5.0M | 6.37 | |
| Bluebird Bio (BLUE) | 1.7 | $25M | 657k | 38.57 | |
| Sequenom Com New | 1.6 | $24M | 6.3M | 3.87 | |
| Novavax | 1.4 | $22M | 4.8M | 4.62 | |
| Revance Therapeutics (RVNC) | 1.4 | $21M | 630k | 34.00 | |
| Furiex Pharmaceuticals | 1.4 | $21M | 200k | 106.18 | |
| Amarin Corp Adr (AMRN) | 1.3 | $19M | 11M | 1.76 | |
| Weight Watchers International | 1.1 | $17M | 850k | 20.17 | |
| ICU Medical, Incorporated (ICUI) | 1.1 | $17M | 278k | 60.81 | |
| Bio-Reference Laboratories | 1.1 | $16M | 544k | 30.22 | |
| Geron Corporation (GERN) | 1.1 | $16M | 5.0M | 3.21 | |
| Tornier Nv | 0.9 | $13M | 574k | 23.38 | |
| GenMark Diagnostics | 0.8 | $12M | 908k | 13.53 | |
| Bruker Corporation (BRKR) | 0.8 | $12M | 500k | 24.27 | |
| Cardica | 0.6 | $9.5M | 8.4M | 1.14 | |
| Protalix BioTherapeutics | 0.5 | $7.3M | 2.0M | 3.65 | |
| Targacept | 0.5 | $7.0M | 1.6M | 4.51 | |
| Repros Therapeutics | 0.4 | $6.8M | 390k | 17.30 | |
| AngioDynamics (ANGO) | 0.4 | $6.3M | 384k | 16.33 | |
| Biolase Technology | 0.4 | $6.0M | 2.7M | 2.20 | |
| Cross Country Healthcare (CCRN) | 0.3 | $5.2M | 798k | 6.52 | |
| Orthofix International Nv Com Stk | 0.3 | $4.3M | 119k | 36.25 |
